Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.34 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | GABRP | O00591 | 1/20 | 0.33 |
| ▸ | GABRD | O14764 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6004167 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2A6HDAC8ACHE | |
| SCHEMBL13201579 | 0.89 | CYP2A6 (0.42) | ALDH1A1TSHRCYP2A6HDAC8TDP1 | |
| SCHEMBL1478591 | 0.88 | HDAC8 (0.43) | ALDH1A1HDAC8TDP1CA2CA12 | |
| SCHEMBL6279069 | 0.87 | ALDH1A1 (0.38) | ALDH1A1TSHRCYP2A6ACHETDP1 | |
| SCHEMBL23059787 | 0.86 | PTPN1 (0.40) | ALDH1A1TSHRACHEKCNH2CA2 | |
| SCHEMBL121302 | 0.85 | — | — | |
| Bromide SCHEMBL28139811 | 0.83 | ALDH1A1 (0.50) | ALDH1A1CYP2A6HDAC8ACHETDP1 | |
| SCHEMBL28344843 | 0.83 | ALDH1A1 (0.50) | ALDH1A1CYP2A6HDAC8ACHETDP1 | |
| Hydrochloric Acid SCHEMBL28998656 | 0.83 | ALDH1A1 (0.50) | ALDH1A1CYP2A6HDAC8ACHETDP1 | |
| SCHEMBL27596658 | 0.83 | ALDH1A1 (0.50) | ALDH1A1CYP2A6HDAC8ACHETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7875748-B2 | Prepared by reaction of tetraphenylcyclopentadienone with 1,4-diethynyl-2,5-dimethoxybenzene; can be used as a core material for an organic electroluminescence element or other optical devices | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2011-01-25 | — | — | US | disclosed |
| US-7875748-B2 | Prepared by reaction of tetraphenylcyclopentadienone with 1,4-diethynyl-2,5-dimethoxybenzene; can be used as a core material for an organic electroluminescence element or other optical devices | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2011-01-25 | — | — | US | disclosed |
| US-7875748-B2 | Prepared by reaction of tetraphenylcyclopentadienone with 1,4-diethynyl-2,5-dimethoxybenzene; can be used as a core material for an organic electroluminescence element or other optical devices | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2011-01-25 | — | — | US | disclosed |
| US-20090240062-A1 | COMPOUND DERIVED FROM CYCLOPENTADIENONE, PREPARATION METHOD THEREOF AND EL ELEMENT USING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2009-09-24 | — | — | US | disclosed |
| US-20090240062-A1 | COMPOUND DERIVED FROM CYCLOPENTADIENONE, PREPARATION METHOD THEREOF AND EL ELEMENT USING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2009-09-24 | — | — | US | disclosed |
| US-20090240062-A1 | COMPOUND DERIVED FROM CYCLOPENTADIENONE, PREPARATION METHOD THEREOF AND EL ELEMENT USING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2009-09-24 | — | — | US | disclosed |
| US-20050067955-A1 | Compound derived from cyclopentadienone, preparation method thereof and EL element using the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2005-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090240062-A1 | COMPOUND DERIVED FROM CYCLOPENTADIENONE, PREPARATION METHOD THEREOF AND EL ELEMENT USING THE SAME | ELP1, CYP51A1, ELOVL1 | ALDH1A1 525/4885TSHR 4852/4885CYP2A6 694/4885 |
| US-20050067955-A1 | Compound derived from cyclopentadienone, preparation method thereof and EL element using the same | ELP1, CYP51A1, ELOVL1 | ALDH1A1 525/4885TSHR 4852/4885CYP2A6 694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.